Investors Connect Biopharma is clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary Disease (COPD) Press Releases April 23, 2026 Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis March 31, 2026 Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update March 30, 2026 Connect Biopharma Announces $20.2 Million Private Placement Financing FRONT >> News > View All View all press releases Upcoming Events More events are coming soon. FRONT > Events - View All View all events Stock Quote Change Volume Today's Open Previous Close Minimum 15 minutes delayed. Source: LSEG FRONT >> Stock > View All View detailed stock information
April 23, 2026 Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
March 31, 2026 Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
